Markets:

News

Articles published by Faeth Therapeutics

Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference

August 07, 2026

From Faeth Therapeutics

Via Business Wire

Tickers FTH

Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates

August 04, 2026

From Faeth Therapeutics

Via Business Wire

Tickers FTH

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer

October 27, 2025

From Faeth Therapeutics

Via Business Wire

ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy

October 19, 2025

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics’ R&D Platform Delivers First Cross-Disease Validation Beyond Oncology

September 30, 2025

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Announces Late-Breaking Presentation of Positive Phase 2 Data in Ovarian Cancer at ESMO 2025

September 24, 2025

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Shows Preclinical Proof-of-Concept for Drug-Diet Combination to Treat Cancer, in Peer-Reviewed Publication

May 13, 2025

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer

March 12, 2025

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors

November 22, 2024

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase

July 17, 2024

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics to Participate in Upcoming Jefferies Investor Conference

May 30, 2024

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics to Participate in the Stifel 2023 Healthcare Conference

November 08, 2023

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Announces National Academy of Medicine Recognition for Co-founder Dr. Siddhartha Mukherjee

October 13, 2023

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., as Chief Medical Officer

September 29, 2023

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Expands Leadership Team with Thomas Strack as Chief Medical Officer and Virginia Casadas as Head of Clinical Operations

April 11, 2022

From Faeth Therapeutics

Via Business Wire

Faeth Therapeutics Raises $20M to Advance Precision Nutrition Platform as A New Modality in Cancer Treatment

January 18, 2022

From Faeth Therapeutics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.